Fresenius Kabi iPSUM

…is one of the leaders in sterile manufacturing of beta-lactam Active Pharmaceutical  Ingredients (APIs) supplying over 50 different products to more than 70 countries.


Fresenius Kabi iPSUM is a part of the Fresenius Kabi group, specialized in cGMP manufacturing of API beta-lactam antibiotics both oral and sterile grades. Since the foundation of the company in 1975, Fresenius Kabi Anti-Infectives has been continuously developing its presence in the field of semi-synthetic Penicillins and Cephalosporins with the main focus on sterile production.

The latest state of the art facilities are approved by all major health authorities including FDA, EDQM and AIFA. The company’s portfolio is complemented with several new APIs every year as Fresenius Kabi Anti-Infectives is strongly committed to development and launch of first to market generic APIs .